Costs of moderate to severe chronic pain in primary care patients - A study of the ACCORD Program

Journal of Pain Research

Volumn 7, Issue , 2014, Pages 389-403

  Lalonde, Lyne ^a,b,c   Choinière, Manon ^a,c   Martin, Élisabeth ^b,c   Berbiche, Djamal ^b,c   Perreault, Sylvie ^a   Lussier, David ^a,d,e  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Centre de Sante et de Services Sociaux de Laval   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d CENTRE DE RECHERCHE   (Canada)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

Brief Pain Inventory; Cohort study; Direct health care costs; Noncancer chronic pain; Primary care; Productivity costs

Indexed keywords

ADULT; ARTICLE; CHRONIC PAIN; CLINICAL FEATURE; CONTROLLED STUDY; COST OF ILLNESS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SERVICE; MIDDLE AGED; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PATIENT ASSESSMENT; PRIMARY MEDICAL CARE; PRODUCTIVITY; SCORING SYSTEM; SYNDROME DELINEATION;

EID: 84904035363     PISSN: None     EISSN: 11787090     Source Type: Journal    
DOI: 10.2147/JPR.S55388     Document Type: Article

References (60)

1. Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Prepared by the International Association for the Study of Pain, Subcommittee on Taxonomy. Pain Suppl. 1986; 3: S1-S226.
2. Moulin DE, Clark AJ, Speechley M, Morley-Forster PK. Chronic pain in Canada-prevalence, treatment, impact and the role of opioid analgesia. Pain Res Manag. 2002; 7(4): 179-184.
3. Boulanger A, Clark AJ, Squire P, Cui E, Horbay GL. Chronic pain in Canada: have we improved our management of chronic noncancer pain? Pain Res Manag. 2007; 12(1): 39-47.
4. Millar WJ. Chronic pain. Health Rep. 1996; 7(4): 47-53, 51-58.
5. Ospina M, Harstall C. Prevalence of Chronic Pain: An Overview. Edmonton, AB: Alberta Heritage Foundation for Medical Research; 2002. Available from: http: //ihe. ca/documents/prevalence_chronic_pain_0. pdf. Accessed April 6, 2011.
6. Kerr S, Fairbrother G, Crawford M, Hogg M, Fairbrother D, Khor KE. Patient characteristics and quality of life among a sample of Australian chronic pain clinic attendees. Intern Med J. 2004; 34(7): 403-409.
7. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006; 10(4): 287-333.
8. Gureje O, Von Korff M, Simon GE, Gater R. Persistent pain and well-being: a World Health Organization Study in Primary Care. JAMA. 1998; 280(2): 147-151.
9. McWilliams LA, Cox BJ, Enns MW. Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sample. Pain. 2003; 106(1-2): 127-133.
10. Fautrel B, Clarke AE, Guillemin F, etal. Costs of rheumatoid arthritis: new estimates from the human capital method and comparison to the willingness-to-pay method. Med Decis Making. 2007; 27(2): 138-150.
11. Lachaine J, Beauchemin C, Landry PA. Clinical and economic characteristics of patients with fibromyalgia syndrome. Clin J Pain. 2010; 26(4): 284-290.
12. Lachaine J, Gordon A, Choinière M, Collet JP, Dion D, Tarride JE. Painful neuropathic disorders: an analysis of the Régie de l'Assurance Maladie du Québec database. Pain Res Manag. 2007; 12(1): 31-37.
13. Agence d'évaluation des technologies et des modes d'intervention en santé. Management of Chronic (Non-Cancer) Pain: Organization of Health Services. Montreal, QC: Agence d'évaluation des technologies et des modes d'intervention en santé; 2006
14. van Leeuwen MT, Blyth FM, March LM, Nicholas MK, Cousins MJ. Chronic pain and reduced work effectiveness: the hidden cost to Australian employers. Eur J Pain. 2006; 10(2): 161-166.
15. Kumpusalo E, Mäntyselkä P, Takala J. Chronic pain in primary care. Fam Pract. 2000; 17(4): 352.
16. Pizzi LT, Carter CT, Howell JB, Vallow SM, Crawford AG, Frank ED. Work loss, healthcare utilization, and costs among US employees with chronic pain. Disease Management and Health Outcomes. 2005; 13(3): 201-208.
17. Michaud K, Messer J, Choi HK, Wolfe F. Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7, 527 patients. Arthritis Rheum. 2003; 48(10): 2750-2762.
18. Yelin E, Wanke LA. An assessment of the annual and long-term direct costs of rheumatoid arthritis: the impact of poor function and functional decline. Arthritis Rheum. 1999; 42(6): 1209-1218.
19. Clarke AE, Zowall H, Levinton C, etal. Direct and indirect medical costs incurred by Canadian patients with rheumatoid arthritis: a 12 year study. J Rheumatol. 1997; 24(6): 1051-1060.
20. Burton W, Morrison A, Maclean R, Ruderman E. Systematic review of studies of productivity loss due to rheumatoid arthritis. Occup Med (Lond). 2006; 56(1): 18-27.
21. Gaskin DJ, Richard P. The economic costs of pain in the United States. J Pain. 2012; 13(8): 715-724.
22. Maetzel A, Li LC, Pencharz J, Tomlinson G, Bombardier C; Community Hypertension and Arthritis Project Study Team. The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study. Ann Rheum Dis. 2004; 63(4): 395-401.
23. Penrod JR, Bernatsky S, Adam V, Baron M, Dayan N, Dobkin PL. Health services costs and their determinants in women with fibromyalgia. J Rheumatol. 2004; 31(7): 1391-1398.
24. Guerriere DN, Choinière M, Dion D, etal. The Canadian STOP-PAIN project-Part 2: What is the cost of pain for patients on waitlists of multidisciplinary pain treatment facilities? Can J Anaesth. 2010; 57(6): 549-558.
25. Lalonde L [webpage on the Internet]. Optimisation de la gestion de la douleur chronique en soins de première ligne [Optimizing the management of chronic pain in ambulatory primary care]. ACCORD Regroupment des forces pour gérer la douleur chronique; Montreal, QC; 2009. Available from: http: //www. programmeaccord. org/volets/premiereligne. Accessed April 22, 2013.
26. Jouini G, Choiniere M, Martin E, Perreault S, Berbiche D, Lussier D et al. Pharmacotherapeutic management of chronic noncancer pain in primary care: lessons for pharmacists. J Pain Res. 2014; 7: 163-173.
27. Atlas de la santé et des services sociaux du Québec! [webpage on the Internet]. Québec: Santé et Services sociaux Québec; 2014. Available from: http: //www. msss. gouv. qc. ca/statistiques/atlas/atlas/index. php. Accessed May 12, 2014.
28. Hoffman DL, Sadosky A, Dukes EM, Alvir J. How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy? Pain. 2010; 149(2): 194-201.
29. World Health Organization. A new understanding of chronic pain. In: Kaplun A, editor. Health Promotion and Chronic Illness. Discovering a New Quality of Health. Copenhagen, Denmark: WHO Regional Publications; 1992; 141-226.
30. Jovey RD, Ennis J, Gardner-Nix J, etal; Canadian Pain Society. Use of opioid analgesics for the treatment of chronic noncancer pain-a consensus statement and guidelines from the Canadian Pain Society, 2002. Pain Res Manag. 2003; 8 Suppl A: 3A-28A.
31. Merskey H, Bogduk N, editors. Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definition of Pain Terms. Seattle, WA: IASP Press; 2011.
32. Beaudry N [webpage on the Internet]. Les tarifs des spécialistes de la santé en 2007 [The rates of health care professionals in 2007]. Montreal, QC: Normandin Beaudry; Communiqué. 2007; 10(12). Available from: http: //www. normandin-beaudry. ca/publications/communiques/archives/2007/vol10-n12. fr. html. Accessed November 4, 2013.
33. Moulin DE, Clark AJ, Gilron I, etal; Canadian Pain Society. Pharmacological management of chronic neuropathic pain-consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag. 2007; 12(1): 13-21.
34. O'Connor AB, Dworkin RH. Treatment of neuropathic pain: an overview of recent guidelines. Am J Med. 2009; 122(Suppl 10): S22-S32.
35. Harpaz R, Ortega-Sanchez IR, Seward JF; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008; 57(RR-5): 1-30; quiz CE2-CE4.
36. Régie de l'assurance maladie du Québec. List of Medications. Gatineau, QC: Service des relations avec la clientele; 2011. Available from: https: //www. prod. ramq. gouv. qc. ca/DPI/PO/Commun/PDF/Liste_Med/Liste_Med/liste_med_mod1_2011_12_16én. pdf. Accessed April 22, 2013.
37. McKesson Canada [homepage on the Internet]. McKesson Canada. San Francisco, CA: McKesson Corporation; 2013. Available from: https: //www. mckesson. ca. Accessed September 9, 2013.
38. Vigilance Santé [homepage on the Internet]. Vigilance Santé. Repentigny, QC: Vigilance Santé; 2013. Available from: http: //www. vigilance. ca. Accessed September 9, 2013.
39. Statistics Canada [webpage on the Internet]. Salaires horaires moyens des employés selon certaines caractéristiques et occupations, données non désaisonnalisées, par province (mensuel) (Canada). Ottawa, ON: Government of Canada; 2005. Available from: http: //www. statcan. gc. ca/tables-tableaux/sum-som/l02/cst02/labr69a-fra. htm. Accessed September 9, 2013.
40. Statistics Canada [webpage on the Internet]. Labour force survey estimates (LFS), by sex and detailed age group annual (persons x 1, 000). Ottawa, ON: Government of Canada; 2014. Available from: http: //www5. statcan. gc. ca/cansim/a05?lang=eng&id=2820002. Accessed September 9, 2013.
41. Commission des normes du travail du Québec [webpage on the Internet]. History of the minimum wage. Québec, QC: Commission des norms du travail Québec; Available from: http: //www. cnt. gouv. qc. ca/en/wages-pay-and-work/wages/history-of-the-minimum-wage/index. html. Accessed August 26, 2013.
42. Hu XH, Markson LE, Lipton RB, Stewart WF, Berger ML. Burden of migraine in the United States: disability and economic costs. Arch Intern Med. 1999; 159(8): 813-818.
43. Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore. 1994; 23(2): 129-138.
44. Tyler EJ, Jensen MP, Engel JM, Schwartz L. The reliability and validity of pain interference measures in persons with cerebral palsy. Arch Phys Med Rehabil. 2002; 83(2): 236-239.
45. Kosinski M, Janagap CC, Gajria K, Schein J. Psychometric testing and validation of the Chronic Pain Sleep Inventory. Clin Ther. 2007; 29 Suppl: 2562-2577.
46. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67(6): 361-370.
47. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40(5): 373-383.
48. Consumer Price Index, historical summary (1994 to 2013) [webpage on the Internet]. Ottawa: Statistics Canada, Government of Canada [updated January 24, 2014]. Available from: http: //www. statcan. gc. ca/tables-tableaux/sum-som/l01/cst01/econ46a-eng. htm. Accessed May 12, 2014.
49. Verstappen SM, Verkleij H, Bijlsma JW, etal. Determinants of direct costs in Dutch rheumatoid arthritis patients. Ann Rheum Dis. 2004; 63(7): 817-824.
50. Walen HR, Cronan PA, Bigatti SM. Factors associated with healthcare costs in women with fibromyalgia. Am J Manag Care. 2001; 7 Spec No: SP39-SP47.
51. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995; 38(1): 19-28.
52. Manning WG. The logged dependent variable, heteroscedasticity, and the retransformation problem. J Health Econ. 1998; 17(3): 283-295.
53. Fleming S, Rabago DP, Mundt MP, Fleming MF. CAM therapies among primary care patients using opioid therapy for chronic pain. BMC Complement Altern Med. 2007; 7: 15.
54. Ekman M, Jönhagen S, Hunsche E, Jönsson L. Burden of illness of chronic low back pain in Sweden: a cross-sectional, retrospective study in primary care setting. Spine (Phila Pa 1976). 2005; 30(15): 1777-1785.
55. Robinson RL, Birnbaum HG, Morley MA, Sisitsky T, Greenberg PE, Claxton AJ. Economic cost and epidemiological characteristics of patients with fibromyalgia claims. J Rheumatol. 2003; 30(6): 1318-1325.
56. Silverman S, Dukes EM, Johnston SS, Brandenburg NA, Sadosky A, Huse DM. The economic burden of fibromyalgia: comparative analysis with rheumatoid arthritis. Curr Med Res Opin. 2009; 25(4): 829-840.
57. White AG, Birnbaum HG, Janagap C, Buteau S, Schein J. Direct and indirect costs of pain therapy for osteoarthritis in an insured population in the United States. J Occup Environ Med. 2008; 50(9): 998-1005.
58. Jacobsson LT, Lindroth Y, Marsal L, Juran E, Bergström U, Kobelt G. Rheumatoid arthritis: what does it cost and what factors are driving those costs? Results of a survey in a community-derived population in Malmö, Sweden. Scand J Rheumatol. 2007; 36(3): 179-183.
59. Pugner KM, Scott DI, Holmes JW, Hieke K. The costs of rheumatoid arthritis: an international long-term view. Semin Arthritis Rheum. 2000; 29(5): 305-320.
60. Tarride JE, Collet JP, Choinière M, Rousseau C, Gordon A. The economic burden of neuropathic pain in Canada. J Med Econ. 2006; 9(1-4): 55-68.